Asper Reprogenetics News

Published 18/05/2020

Female infertility and male factor infertility panels have undergone an extensive upgrade. The panels now consist of 128 and 138 genes respectively. Female infertility panel also contains testing of CGG trinucleotide repeat in the FMR1 gene. Please see www.asperbio.com/asper-reprogenetics/ for more information.

Updated NGS panels

Published 28/04/2020

Several NGS panels have been updated, including panels for Brain Malformations, Spinocerebellar Ataxias, and Sensorineural Hearing Loss. Find more about updates at www.asperbio.com/NGS-panels

Important announcement

Published 18/03/2020

In critical situation, due to COVID-19 faced by many countries we would like to ensure that we continue providing you with genetic testing services. Our key goal is to continuously offer diagnostic solutions that support healthcare professionals with valuable information and thus contribute to improving patient care. We are committed to maintain the highest level of quality standards in all operations.

In our everyday practice, we follow the WHO guidelines and protective measures of national health authorities to establish safety and health of our employees and customers.

Our laboratory team, clinical and scientific teams are operational and available as usual. As well as customer service will continue to offer assistance. If any new information under these changing circumstances become available we will notify you as soon as possible.

Be safe and healthy! If we can be any of assistance, please do not hesitate to contact us.

Male Factor Infertility test

Published 22/11/2019

Male Factor Infertility test has been upgraded from targeted mutation analysis to NGS panel with 60 genes associated with spermatogenic failure and meiotic arrest. Testing for Klinefelter syndrome and AZF deletions is also available. Visit www.asperbio.com/male-factor-infertility to see the full list of genes.

Asper Nephrology

Published 29/08/2019

We have launched Asper Nephrology testing portfolio to expand our testing menu and cover more clinical areas. The new portfolio includes tests for common monogenic diseases, as well as complex disorders. To establish the genetic cause of renal diseases we use next-generation sequencing technology to accommodate a broad differential diagnosis. CNV analysis based on sequencing data is also available to enhance precise diagnosis. Visit https://www.asperbio.com/asper-nephrology/ to see the full list of tests.

CNV analysis

Published 13/08/2019

We have integrated copy number variation (CNV) detection tool into our everyday workflow. CNV analysis is now available as a new testing option for all NGS panels and whole exome sequencing. 

View the complete list of all tests www.asperbio.com/genetic-tests/

Asper Cardiogenetics updates

Published 19/07/2019

We now offer an NGS panel for Hereditary Hemorrhagic Telangiectasia. Additionally, Noonan Syndrome test has been upgraded to Noonan Spectrum Disorders/Rasopathies test including several new disease-causing genes. All NGS panels in Asper Cardiogenetics testing menu are covered by CNV analysis based on sequencing data. Visit https://www.asperbio.com/asper-cardiogenetics/ to learn more.

Updated Asper Oncogenetics menu

Published 11/07/2019

We have updated our Asper Oncogenetics menu. Genetic testing for Prostate Cancer is now available. The testing includes sequencing of the panel of genes and CNV analysis. Other NGS panels in the Asper Oncogenetics menu now also include CNV analysis. View our updated pricelist at www.asperbio.com/Asper Oncogenetics

News in Asper Ophthalmics

Published 04/07/2019

We are pleased to announce that our NGS panels now include CNV analysis.

In addition, three new genes have been added to the Bardet-Biedl Syndrome panel.

Visit www.asperbio.com/asper-ophthalmics to learn more about our new testing options and see the updated price list.

Asper Dermatology

Published 21/01/2019

We are proud to announce a brand new testing menu – Asper Dermatology, which includes gene panels targeting the diagnostics of different skin related inherited disorders. New panels also facilitate differential diagnosis of diseases with overlapping features. Visit www.asperbio.com/asper-dermatology/ to find out more.